March 11 (SeeNews) - Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] has recorded a consolidated net profit of 10.4 million euro ($11.4 million) in 2023, down from 13.1 million euro in the previous year, it said on Monday.